Skip to main content
NIH funding notice RFA-AG-22-014

NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional)

Closed on October 26, 2021.

Posted
June 10, 2021
Close date
October 26, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $555,803 in first-year total cost, median $555,803.

Most frequent study sections

  1. Special Emphasis Panel[ZAG1 ZIJ-1 (M3)]1

Most frequent institutions

  1. GATEWAY BIOTECHNOLOGY, INC.1
Competing awards under RFA-AG-22-014 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Developing a clinical diagnostic tool for age-related cochlear synaptopathy.1R42AG078721-01PINKL, JOSEPHGATEWAY BIOTECHNOLOGY, INC., MO$555,803ZAG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.